SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-050199
Filing Date
2015-02-13
Accepted
2015-02-13 16:41:38
Documents
1
Group Members
ANDERS HOVEBONG KOHVENROCK ASSOCIATES VI, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS, L.P.VENROCK MANAGEMENT VI, LLCVENROCK PARTNERS MANAGEMENT VI, LLCVENROCK PARTNERS VI, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT

Document Format Files

Seq Description Document Type Size
1 SC 13G d873034dsc13g.htm SC 13G 257648
  Complete submission text file 0001193125-15-050199.txt   259610
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 15615502
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G